Exploring the Impacts of Predictor Variables on Success in a Mental Health Diversion Program

Since the first Mental Health Court (MHC) in 1997, there has been a steady increase of MHCs all over the country. With the introduction of these new specialty courts have also come to introduction of diversion programs. Diversion programs work to connect offenders who have mental illnesses to community-based mental health treatment services as an alternative to incarceration. Typically, with the completion of the program comes with the benefit of having their charges dropped. Diversion programs aim to reduce recidivism in offenders with mental illness and improve their access to treatment

Exploring the Impacts of Predictor Variables on Success in a Mental Health Diversion Program

Since the first Mental Health Court (MHC) in 1997, there has been a steady increase of MHCs all over the country. With the introduction of these new specialty courts have also come to introduction of diversion programs. Diversion programs work to connect offenders who have mental illnesses to community-based mental health treatment services as an alternative to incarceration. Typically, with the completion of the program comes with the benefit of having their charges dropped. Diversion programs aim to reduce recidivism in offenders with mental illness and improve their access to treatment

Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use.

Inhalers and nebulisers are devices used for delivering aerosolised drugs in subjects with Chronic Airflow Obstruction (CAO). This multicentre, cross-sectional observational study was performed in a large population of outpatients with CAO regularly using home aerosol therapy and referring to chest clinics. The aims of the study were to compare the characteristics of the group of subjects with CAO who were using home nebulisers but also experienced with inhalers vs. those only using inhalers and to investigate whether the first group of subjects was particularly prone to inhaler misuse. Information was gained evaluating the responses to a standardised questionnaire on home aerosol therapy and the observations of inhaler technique. We enrolled 1527 patients (58\% males; mean ± SE; aged 61.1 ± 0.4 years; FEV1\% pred 69.9 ± 0.6; 51\% and 44\% respectively suffering from COPD and asthma) who were only inhaler users (OIU group) and 137 (85\% males; aged 67.7 ± 1.3 years; FEV1\% pred 62.3 ± 2.9; 60\% and 23\% respectively suffering from COPD and asthma) who were using both nebulisers and inhalers (NIU group). Nebuliser users were older, had more severe obstruction, related symptoms and health care resources utilisation. Nebulisers users performed more critical inhalers errors than those of the OIU group (49\% vs. 36\%; p = 0.009). We conclude that our patients with CAO and regular nebuliser treatment had advanced age, severe respiratory conditions and common inhaler misuse